Latka logo

Top 2 Drug Discovery Software Companies With $5M–$10M Revenue (November 2026)

As of November 2026, Latka tracks 2 drug discovery software companies with $5M–$10M in annual revenue. They have combined revenues of $14.4M and employ 77 people.

Every company below sells drug discovery software to other businesses and is ranked by its most recent annual revenue. Revenue, funding, headcount and customer figures come from CEO interviews on the Latka podcast, public company filings, and Latka estimates where a company has not disclosed a number.

What Drug Discovery Software Companies do

Drug Discovery Software encompasses a range of tools and applications that aid in the development of new pharmaceuticals. These solutions streamline the research process by enabling researchers to design, analyze, and optimize drug candidates more efficiently. Common use cases include target identification, lead optimization, and preclinical trials, wherein software facilitates simulations and predictions that guide decision-making during the drug discovery pipeline. Typically, drug discovery software features include molecular modeling, compound library management, virtual screening, and data analysis capabilities. Users of this software include pharmaceutical companies, biotech firms, and academic institutions focused on drug development. By automating complex processes, these tools help researchers reduce costs and timeframes associated with bringing new medicines to market.

Companies
2
Revenue
$14.4M
Funding
-
Employees
77

Filters

Sorting: Highest -> Lowest

Filters

Top Drug Discovery Software Companies With $5M–$10M Revenue

Showing 2 of 2 companies ranked by annual revenue.

1WhiteLab Genomics logo
WhiteLab Genomics

Paris, France

Unleashing the potential of DNA and RNA based therapies using AI

Revenue
$7.4M
Year founded
2019
Team size
50
2Antiverse logo
Antiverse

Cardiff, Wales, United Kingdom

Antiverse is a Welsh techbio company specializing in antibody design for challenging drug targets, utilizing advanced machine learning techniques to develop de novo antibody therapeutics.

Revenue
$7M
Year founded
2017
Team size
27

Frequently asked questions about Drug Discovery Software Companies With $5M–$10M Revenue

How many drug discovery software companies with $5M–$10M in annual revenue are there?

Latka tracks 2 drug discovery software companies with $5M–$10M in annual revenue. Together they generate $14.4M in annual revenue and employ 77 people.

Which drug discovery software company with $5M–$10M in annual revenue is the largest?

WhiteLab Genomics is the largest, with $7.4M in annual revenue, founded in 2019.

How much revenue does a typical drug discovery software company with $5M–$10M in annual revenue make?

The average drug discovery software company in this list makes $7.2M a year, across 2 companies with reported revenue.

Who are the leading Drug Discovery software vendors with $5M–$10M in annual revenue?

Ranked by annual revenue, the leaders are WhiteLab Genomics and Antiverse.

Related Vertical Industry Software categories

Inclusion Criteria

- Offers tools for molecular modeling and simulations - Supports data analysis related to drug interactions and efficacy - Aids in target identification and validation in the drug discovery process - Includes features for library management of drug compounds - Must facilitate preclinical trial planning and analysis - Not just general research software; must specifically cater to drug discovery workflows